PDF

摘要/Abstract

摘要： 背景与目的：N-Myc下游调节基因2（N-Myc down stream-regulated gene 2，NDRG2）是一种新发现的抑癌基因，在细胞增殖和凋亡中发挥着重要作用，膀胱癌的化疗耐药是临床治疗失败的主要原因之一。阐明NDRG2蛋白在膀胱癌中的表达及顺铂（cisplatin，CDDP）抗性形成的机制。方法：将膀胱癌T24细胞通过CDDP浓度递增的方式连续传代，持续6个月，获得CDDP抗性T24/CR细胞株；通过质粒转染方式使得T24/CR中NDRG2过表达，采用MTT法测定细胞活力，采用凋亡和transwell侵袭实验等比较NDRG2过表达对T24细胞CDDP抗性的影响，随后用Bcl-2-siRNA瞬时转染敲低T24细胞中NDRG2的表达，并通过蛋白质印迹法（Western blot）检测两者之间的表达变化，从而了解两者之间的相关性，采用实时荧光定量聚合酶链反应（real-time fluorescence quantitative polymerase chain reaction，RTFQ-PCR）检测NDRG2 mRNA的表达。结果：NDRG2的表达水平在CDDP抗性膀胱癌细胞中显著下调。外源性NDRG2过表达，增强了CDDP的敏感性并且在CDDP存在下抑制膀胱癌细胞的活力和侵袭。下调NDRG2的表达对Bcl-2的表达无明显影响，而下调Bcl-2的表达可有效解除NDRG2低表达对膀胱癌细胞活力和凋亡的影响，并恢复CDDP对膀胱癌细胞的敏感性。结论：NDRG2/Bcl-2的失衡可能是晚期膀胱癌中CDDP抗性形成的关键机制，NDRG2有望成为CDDP抗性或难治性膀胱癌治疗的新靶点。

关键词: 顺铂, N-Myc下游调节基因2, 耐药, Bcl-2

Abstract: Background and purpose: N-Myc down stream-regulated gene 2 (NDRG2) is a new type of tumor suppressor gene, which plays an important role in cell proliferation and apoptosis. The chemotherapy resistance of bladder cancer is the main cause for the failure of clinical treatment; therefore, this study aimed to clarify the expression of NDRG2 and its potential role in the pathogenesis of cisplatin (CDDP) resistance in bladder cancer cells. Methods: Bladder cancer T24 cells were continuously passaged by increasing the CDDP concentration for 6 months to obtain CDDP-resistant T24/CR cell lines. Lentiviral transfection was used to achieve high expression of NDRG2 in T24/CR. Cell viability was measured by MTT, apoptosis and transwell invasion assay were performed. The effect of NDRG2 overexpression on T24 cell resistance to CDDP was compared. Bcl-2-siRNA transient transfection was used to knock down the expression of NDRG2 in T24 cells, and then the expression in different groups was detected by Western blot. Real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR) was used to detect the expression level of NDRG2 mRNA. Results: The expression level of NDRG2 was significantly down-regulated in CDDP-resistant bladder cancer cells. Exogenous overexpression of NDRG2 enhanced the sensitivity to CDDP and inhibited the viability and invasion of bladder cancer cells in the presence of CDDP. Knockdown of NDRG2 expression had no significant effect on the expression of Bcl-2. Knockdown of Bcl-2 could effectively eliminate the effect of low NDRG2 expression on the viability and apoptosis of bladder cancer cells, and could restore the sensitivity to CDDP in bladder cancer cells. Conclusion: The unbalance of NDRG2/Bcl-2 maybe the key mechanism of CDDP resistance in advanced bladder cancer. Enhanced expression of NDRG2 might be used as a candidate for the treatment of CDDP-resistant or refractory bladder cancer.

Key words: Cisplatin, N-Myc down steam-regulated gene 2, Resistance, Bcl-2

李瑞晓, 唐启胜, 马善金, 张　波, 李雪莲, 张志明 . NDRG2通过抑制Bcl-2表达增加膀胱癌细胞对顺铂的敏感性[J]. 中国癌症杂志, 2021, 31(4): 263-267.

LI Ruixiao , TANG Qisheng , MA Shanjin , ZHANG Bo , LI Xuelian , ZHANG Zhiming . NDRG2 increases bladder cancer cell sensitivity to cisplatin by inhibiting Bcl-2 expression[J]. China Oncology, 2021, 31(4): 263-267.

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://www.china-oncology.com/CN/10.19401/j.cnki.1007-3639.2021.04.004

http://www.china-oncology.com/CN/Y2021/V31/I4/263

[1]	刘懿萱 , 文泽轩 , 郭　林 , 卢仁泉 . TTK1在卵巢癌铂类耐药中的生物学功能分析[J]. 中国癌症杂志, 2021, 31(3): 182-191.
[2]	汪　明, 曹　晖. 晚期胃肠间质瘤药物治疗进展[J]. 中国癌症杂志, 2021, 31(2): 90-99.
[3]	马　倩, 刘懿萱, 开今言, 郭　林, 卢仁泉 . Ku86通过调控TOP1和COPS5影响上皮性卵巢癌细胞对于顺铂的化疗敏感性[J]. 中国癌症杂志, 2021, 31(2): 100-107.
[4]	李芷君, 徐兵河. 乳腺癌芳香化酶抑制剂耐药的研究进展[J]. 中国癌症杂志, 2021, 31(2): 81-89.
[5]	叶星明, 王　淋, 贾　静, 吴秀凤, 陈　颖 . miR-375靶向YAP1调控上皮-间质转化参与乳腺癌细胞曲妥珠单抗的耐药[J]. 中国癌症杂志, 2021, 31(1): 27-34.
[6]	祝开忠, 王挺锐, 陈焕雄, 陈　涛, 钟贞浩. 骨肉瘤中O-GlcNAc糖基转移酶的表达及其对增殖和顺铂敏感性的影响[J]. 中国癌症杂志, 2020, 30(9): 682-688.
[7]	郭　莉, 杨顺娥, 李　迅. 新疆ABCG2基因多态性与乳腺癌复发的相关性研究[J]. 中国癌症杂志, 2020, 30(5): 340-346.
[8]	程淇, 易晓芳 . 铁死亡在肿瘤耐药中作用的研究进展[J]. 中国癌症杂志, 2020, 30(2): 148-153.
[9]	周　舰, 张朝阳, 孙　伟, 杨　军, 张志超, 戚晓红. miR-503靶向TLR4对前列腺癌多西他赛耐药的影响[J]. 中国癌症杂志, 2020, 30(11): 858-864.
[10]	洪少东, 张　力. 肺癌靶向治疗新进展及展望[J]. 中国癌症杂志, 2020, 30(10): 733-743.
[11]	王　洁. 免疫检查点抑制剂在肺癌治疗应用中的挑战与方向[J]. 中国癌症杂志, 2020, 30(10): 744-749.
[12]	郑小翠,汪希鹏 . 单细胞测序技术在实体瘤研究中的应用进展[J]. 中国癌症杂志, 2019, 29(7): 535-539.
[13]	李文成，王孝深. 铂类药物在头颈部鳞癌治疗中的选择与应用[J]. 中国癌症杂志, 2019, 29(4): 300-306.
[14]	王春晓, 邱成志, 洪钟时. 沉默GOLPH3基因表达逆转人结肠癌细胞顺铂耐药的研究[J]. 中国癌症杂志, 2019, 29(11): 862-868.
[15]	杨　颖，杨志芳，才　层，张瑞丽，路鹏霏，贾春丽，李志鹏，毛　睿，张　华，包永星. miR-27a-3p对肝癌细胞化疗敏感性的影响及机制探讨[J]. 中国癌症杂志, 2019, 29(10): 788-794.

NDRG2通过抑制Bcl-2表达增加膀胱癌细胞对顺铂的敏感性

PDF

摘要/Abstract

引用本文

使用本文

相关文章